Skip to main content

Table 1 Demographic data, therapeutic intervention modalities and triphasic CT wash-in/out criteria of the studied patients

From: Role of 18F-FDG PET/CT in assessment of HCC patients after therapeutic interventions compared to DW MRI

 

Triphasic CT

Test value

P value

Sig.

Negative

Positive

No. 12

No. 22

Age

Mean ± SD

61.00 ± 6.81

58.64 ± 12.58

0.602

0.551

NS

Range

52–74

20–77

Sex

Female

3 (25.0%)

8 (36.4%)

0.458*

0.498

NS

Male

9 (75.0%)

14 (63.6%)

Therapeutic intervention

TACE

3 (25.0%)

10 (45.5%)

4.640*

0.326

NS

RFA

6 (50.0%)

7 (31.8%)

Ethanol

0 (0.0%)

3 (13.6%)

Surgery

2 (16.7%)

1 (4.5%)

RFA and ethanol

1 (8.3%)

1 (4.5%)

  1. *Chi-square test; Independent t-test
  2. TACE Trans-arterial chemoembolization, RFA radiofrequency ablation, CT computed tomography